Valuation: AtriCure, Inc.

Market Cap 2.85B 2.54B 2.35B 2.14B 4.03B 271B 4.1B 28.25B 11.07B 141B 10.7B 10.48B 450B P/E 2026 *
525x
P/E 2027 * 133x
Enterprise Value 2.7B 2.4B 2.22B 2.02B 3.82B 256B 3.88B 26.74B 10.48B 134B 10.13B 9.92B 426B EV / Sales 2026 *
4.45x
EV / Sales 2027 * 3.86x
Free-Float
96.24%
Yield 2026 *
-
Yield 2027 * -
1 day-2.96%
1 week+0.47%
Current month-0.23%
1 month-1.87%
3 months+57.41%
6 months+94.15%
Current year+41.73%
1 week 55.67
Extreme 55.67
58.44
1 month 51.63
Extreme 51.63
61.7
Current year 25.36
Extreme 25.36
61.7
1 year 25.36
Extreme 25.36
61.7
3 years 18.94
Extreme 18.94
61.7
5 years 18.94
Extreme 18.94
89.18
10 years 14.78
Extreme 14.78
89.18
Manager TitleAgeSince
Chief Executive Officer 55 2012-11-01
Director of Finance/CFO 48 2014-06-30
Chief Tech/Sci/R&D Officer 59 2017-07-17
Director TitleAgeSince
Director/Board Member 55 2012-11-01
Director/Board Member 64 2013-03-10
Director/Board Member 75 2016-11-09
Date Insider Type Main position Quantity % Market Cap. Importance
9/23/26 Sell

Chief Technology Officer

-4,519 0.0089%
9/11/26 Sell

Director

-5,313 0.0104%
9/8/26 Sell

Chief Technology Officer

-3,657 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
-2.96%+0.47%+50.56%+51.99% 2.94B
+0.20%+5.31%-17.82%+13.79% 181B
-0.73%+7.09%-0.31%+32.06% 117B
+0.49%+6.25%-20.20%+11.58% 112B
+3.83%+5.50%-44.18%-6.77% 76.56B
-0.14%+5.27%+6.74%+82.45% 65.15B
+2.79%+2.37%+15.93%+68.64% 52.79B
-1.04%+4.35%+3.50%-26.18% 52.78B
+2.41%+8.18%-12.08%+30.45% 43.11B
-1.67%-0.83% - - 32.08B
Average +0.31%+4.23%-1.98%+28.67% 73.59B
Weighted average by Cap. +0.56%+5.25%-11.12%+22.88%

Financials

2026 *2027 *
Net sales 606M 539M 499M 454M 858M 57.54B 871M 6B 2.35B 30.03B 2.28B 2.23B 95.72B 680M 604M 560M 510M 962M 64.51B 977M 6.73B 2.64B 33.67B 2.55B 2.5B 107B
Net income 7.13M 6.34M 5.88M 5.35M 10.09M 677M 10.25M 70.63M 27.69M 353M 26.77M 26.2M 1.13B 20.89M 18.57M 17.21M 15.66M 29.54M 1.98B 30.02M 207M 81.1M 1.03B 78.39M 76.72M 3.3B
Net Debt -152M -135M -125M -114M -215M -14.41B -218M -1.5B -590M -7.52B -570M -558M -23.98B -227M -201M -187M -170M -320M -21.5B -326M -2.24B -880M -11.22B -850M -832M -35.77B
Projected Income Statement - Annual - AtriCure, Inc.
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
26-10-16 $56.07 -2.96% 648,347
26-10-15 $57.78 +0.84% 850,921
26-10-14 $57.30 +0.76% 799,310
26-10-13 $56.87 -0.72% 596,098
26-10-12 $57.28 +2.63% 645,600
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - AtriCure, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
56.07USD
Average target price
55.78USD
Spread / Average Target
-0.52%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AtriCure, Inc.
  1. Stock Market
  2. Stocks
  3. ATRC Stock